← FDA Drug Approvals (Drugs@FDA)
RIVASTIGMINE TARTRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2017-09-28
Drug application
- FDA Application #
ANDA207797- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIVASTIGMINE TARTRATE
- Generic name
- RIVASTIGMINE TARTRATE
- Active ingredients
- RIVASTIGMINE TARTRATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CHARTWELL RX
- Manufacturer
- Chartwell RX, LLC
- First approval
- 2017-09-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown